1. Home
  2. NLSP vs TLS Comparison

NLSP vs TLS Comparison

Compare NLSP & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • TLS
  • Stock Information
  • Founded
  • NLSP 2015
  • TLS 1969
  • Country
  • NLSP Switzerland
  • TLS United States
  • Employees
  • NLSP N/A
  • TLS N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • TLS EDP Services
  • Sector
  • NLSP Health Care
  • TLS Technology
  • Exchange
  • NLSP Nasdaq
  • TLS Nasdaq
  • Market Cap
  • NLSP 5.2M
  • TLS 238.1M
  • IPO Year
  • NLSP 2021
  • TLS 2020
  • Fundamental
  • Price
  • NLSP $1.95
  • TLS $3.50
  • Analyst Decision
  • NLSP
  • TLS Buy
  • Analyst Count
  • NLSP 0
  • TLS 6
  • Target Price
  • NLSP N/A
  • TLS $4.80
  • AVG Volume (30 Days)
  • NLSP 535.3K
  • TLS 454.9K
  • Earning Date
  • NLSP 12-31-2024
  • TLS 11-12-2024
  • Dividend Yield
  • NLSP N/A
  • TLS N/A
  • EPS Growth
  • NLSP N/A
  • TLS N/A
  • EPS
  • NLSP N/A
  • TLS N/A
  • Revenue
  • NLSP N/A
  • TLS $122,959,000.00
  • Revenue This Year
  • NLSP N/A
  • TLS N/A
  • Revenue Next Year
  • NLSP N/A
  • TLS $38.31
  • P/E Ratio
  • NLSP N/A
  • TLS N/A
  • Revenue Growth
  • NLSP N/A
  • TLS N/A
  • 52 Week Low
  • NLSP $1.73
  • TLS $1.89
  • 52 Week High
  • NLSP $24.32
  • TLS $5.03
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 34.15
  • TLS 49.00
  • Support Level
  • NLSP $1.73
  • TLS $3.38
  • Resistance Level
  • NLSP $2.79
  • TLS $3.91
  • Average True Range (ATR)
  • NLSP 0.36
  • TLS 0.22
  • MACD
  • NLSP 0.04
  • TLS 0.01
  • Stochastic Oscillator
  • NLSP 14.67
  • TLS 37.88

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: